Blood–brain barrier dysfunction promotes astrocyte senescence through albumin‐induced TGFβ signaling activation
Aging Cell · 2023-02 · 22 (2)
DOI: 10.1111/acel.13747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, online erschienen am 05.01.2023. Verfasst von Marcela K Preininger und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Biology, University of California, Berkeley, Berkeley, California, USA. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Astrocytes. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, National Science Foundation of Sri Lanka.
Abstract (Originalsprache)
Blood–brain barrier dysfunction (BBBD) and accumulation of senescent astrocytes occur during brain aging and contribute to neuroinflammation and disease. Here, we explored the relationship between these two age‐related events, hypothesizing that chronic hippocampal exposure to the blood‐borne protein serum albumin could induce stress‐induced premature senescence (SIPS) in astrocytes via transforming growth factor beta 1 (TGFβ) signaling. We found that 1 week of albumin exposure significantly increased TGFβ signaling and senescence marker expression in cultured rat hippocampal astrocytes. These changes were preventable by pharmacological inhibition of the type I TGFβ receptor (TGFβR) ALK5. To study these effects in vivo, we utilized an animal model of BBBD in which albumin was continuously infused into the lateral ventricles of adult mice. Consistent with our in vitro results, 1 week of albumin infusion significantly increased TGFβ signaling activation and the burden of senescent astrocytes in hippocampal tissue. Pharmacological inhibition of ALK5 TGFβR or conditional genetic knockdown of astrocytic TGFβR prior to albumin infusion was sufficient to prevent albumin‐induced astrocyte senescence. Together, these results establish a link between TGFβ signaling activation and astrocyte senescence and suggest that prolonged exposure to serum albumin due to BBBD can trigger these phenotypic changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Integrative Biology, University of California, Berkeley, Berkeley, California, USA.
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California, USA.
- Department of Biology, San Francisco State University, San Francisco, California, USA.
- Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, California, USA.
ORCID-Profile: Marcela K Preininger
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- National Science Foundation of Sri Lanka
Zitieren
APA
Preininger, M. K., Zaytseva, D., Lin, J. M., & Kaufer, D. (2023). Blood–brain barrier dysfunction promotes astrocyte senescence through albumin‐induced TGFβ signaling activation. Aging Cell, 22(2). https://doi.org/10.1111/acel.13747
Vancouver
Preininger MK, Zaytseva D, Lin JM, Kaufer D. Blood–brain barrier dysfunction promotes astrocyte senescence through albumin‐induced TGFβ signaling activation. Aging Cell. 2023;22(2). doi:10.1111/acel.13747
BibTeX
@article{Preininger2023,
author = {Preininger, Marcela K and Zaytseva, Dasha and Lin, Jessica May and Kaufer, Daniela},
title = {Blood–brain barrier dysfunction promotes astrocyte senescence through albumin‐induced TGFβ signaling activation},
journal = {Aging Cell},
year = {2023},
volume = {22},
number = {2},
doi = {10.1111/acel.13747}
}
EUVIMED